GB0813694D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0813694D0
GB0813694D0 GBGB0813694.7A GB0813694A GB0813694D0 GB 0813694 D0 GB0813694 D0 GB 0813694D0 GB 0813694 A GB0813694 A GB 0813694A GB 0813694 D0 GB0813694 D0 GB 0813694D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0813694.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0813694.7A priority Critical patent/GB0813694D0/en
Publication of GB0813694D0 publication Critical patent/GB0813694D0/en
Priority to PCT/EP2009/059456 priority patent/WO2010010133A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0813694.7A 2008-07-25 2008-07-25 Compounds Ceased GB0813694D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0813694.7A GB0813694D0 (en) 2008-07-25 2008-07-25 Compounds
PCT/EP2009/059456 WO2010010133A1 (en) 2008-07-25 2009-07-22 2-thia-1,3-diazaspirocyclic-substituted phenylacetamides as glt1 mediators for neurological diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0813694.7A GB0813694D0 (en) 2008-07-25 2008-07-25 Compounds

Publications (1)

Publication Number Publication Date
GB0813694D0 true GB0813694D0 (en) 2008-09-03

Family

ID=39746978

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0813694.7A Ceased GB0813694D0 (en) 2008-07-25 2008-07-25 Compounds

Country Status (2)

Country Link
GB (1) GB0813694D0 (en)
WO (1) WO2010010133A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3134406A1 (en) 2014-04-24 2017-03-01 Dart Neuroscience (Cayman) Ltd Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c]pyridine compounds as glyt1 inhibitors
US10040759B2 (en) 2014-11-05 2018-08-07 Dart Neuroscience (Cayman) Ltd. Substituted azetidinyl compounds as GlyT1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0225475D0 (en) * 2002-11-01 2002-12-11 Merck Sharp & Dohme Therapeutic agents
CL2007003590A1 (en) * 2006-12-12 2008-02-29 Wyeth Corp COMPOUNDS DERIVED FROM ARIL SULFAMIDA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN PREVENTION AND TREATMENT OF VASOMOTRIC SYMPTOMS, SEXUAL DYSFUNCTION, GASTROINTESTINAL DISORDERS, TRANST

Also Published As

Publication number Publication date
WO2010010133A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0800367D0 (en) Compounds
GB0813694D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0807047D0 (en) Compounds
GB0805504D0 (en) Compounds
GB0811203D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0810892D0 (en) Compounds
GB0810619D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0808669D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds
GB0808123D0 (en) Compounds
GB0808119D0 (en) Compounds
GB0807911D0 (en) Compounds
GB0803493D0 (en) Compounds
GB0807415D0 (en) Compounds
GB0811450D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)